Login
Home
Charts
Search
Watchlist
Products

Mangalam Drugs and Organics Ltd

MANGALAM·NSE
₹32.60+1.12%Wed, 23 Sept '26 13:13
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Mangalam Drugs and Organics Ltd

MANGALAM
NSE
₹32.60
+1.12%
|Wed, 23 Sept '26 13:13
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹52Cr
Close
Close Price
₹32.60
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
—
PS
Price To Sales
0.22
Revenue
Revenue
₹232Cr
Rev Gr TTM
Revenue Growth TTM
-22.20%
PAT Gr TTM
PAT Growth TTM
-291.91%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
97102778089735750586757
Growth YoY
Revenue Growth YoY%
-8.9-28.8-25.3-38.0-34.2-7.5-0.2
Expenses
ExpensesCr
9091687180636252607356
Operating Profit
Operating ProfitCr
71289910-5-3-2-61
OPM
OPM%
7.211.410.710.99.913.6-8.1-5.7-2.6-8.31.6
Other Income
Other IncomeCr
00000000000
Interest Expense
Interest ExpenseCr
34443445434
Depreciation
DepreciationCr
44444545454
PBT
PBTCr
041112-13-12-10-13-7
Tax
TaxCr
00-2-1021-5001
PAT
PATCr
143310-14-7-10-13-8
Growth YoY
PAT Growth YoY%
158.0-98.3-614.9-373.2-862.8-22,466.744.6
NPM
NPM%
0.53.53.53.41.40.1-24.1-14.8-16.9-19.9-13.4
EPS
EPS₹
0.32.21.71.70.80.0-8.7-4.6-6.2-8.5-4.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
97102778089735750586757
Growth YoY
Revenue Growth YoY%
-8.9-28.8-25.3-38.0-34.2-7.5-0.2
Expenses
ExpensesCr
9091687180636252607356
Operating Profit
Operating ProfitCr
71289910-5-3-2-61
OPM
OPM%
7.211.410.710.99.913.6-8.1-5.7-2.6-8.31.6
Other Income
Other IncomeCr
00000000000
Interest Expense
Interest ExpenseCr
34443445434
Depreciation
DepreciationCr
44444545454
PBT
PBTCr
041112-13-12-10-13-7
Tax
TaxCr
00-2-1021-5001
PAT
PATCr
143310-14-7-10-13-8
Growth YoY
PAT Growth YoY%
158.0-98.3-614.9-373.2-862.8-22,466.744.6
NPM
NPM%
0.53.53.53.41.40.1-24.1-14.8-16.9-19.9-13.4
EPS
EPS₹
0.32.21.71.70.80.0-8.7-4.6-6.2-8.5-4.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
369318232232
Growth
Revenue Growth%
-13.7-27.1-22.2
Expenses
ExpensesCr
351282247241
Operating Profit
Operating ProfitCr
1736-15-9
OPM
OPM%
4.711.3-6.4-3.9
Other Income
Other IncomeCr
0110
Interest Expense
Interest ExpenseCr
14151616
Depreciation
DepreciationCr
15171818
PBT
PBTCr
-115-49-42
Tax
TaxCr
-2-2-4-4
PAT
PATCr
-97-44-38
Growth
PAT Growth%
174.1-760.6-291.9
NPM
NPM%
-2.52.1-19.1-16.5
EPS
EPS₹
-5.74.3-28.1-24.2
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
369318232232
Growth
Revenue Growth%
-13.7-27.1-22.2
Expenses
ExpensesCr
351282247241
Operating Profit
Operating ProfitCr
1736-15-9
OPM
OPM%
4.711.3-6.4-3.9
Other Income
Other IncomeCr
0110
Interest Expense
Interest ExpenseCr
14151616
Depreciation
DepreciationCr
15171818
PBT
PBTCr
-115-49-42
Tax
TaxCr
-2-2-4-4
PAT
PATCr
-97-44-38
Growth
PAT Growth%
174.1-760.6-291.9
NPM
NPM%
-2.52.1-19.1-16.5
EPS
EPS₹
-5.74.3-28.1-24.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
161616
Reserves
ReservesCr
12013387
Current Liabilities
Current LiabilitiesCr
164192197
Non Current Liabilities
Non Current LiabilitiesCr
342615
Total Liabilities
Total LiabilitiesCr
334366315
Current Assets
Current AssetsCr
176199156
Non Current Assets
Non Current AssetsCr
158167159
Total Assets
Total AssetsCr
334366315
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
161616
Reserves
ReservesCr
12013387
Current Liabilities
Current LiabilitiesCr
164192197
Non Current Liabilities
Non Current LiabilitiesCr
342615
Total Liabilities
Total LiabilitiesCr
334366315
Current Assets
Current AssetsCr
176199156
Non Current Assets
Non Current AssetsCr
158167159
Total Assets
Total AssetsCr
334366315

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4434
Investing Cash Flow
Investing Cash FlowCr
-12-19-12
Financing Cash Flow
Financing Cash FlowCr
5-226
Net Cash Flow
Net Cash FlowCr
-31-2
Free Cash Flow
Free Cash FlowCr
-823
CFO To PAT
CFO To PAT%
-43.1633.8-9.4
CFO To EBITDA
CFO To EBITDA%
22.5118.9-28.0
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4434
Investing Cash Flow
Investing Cash FlowCr
-12-19-12
Financing Cash Flow
Financing Cash FlowCr
5-226
Net Cash Flow
Net Cash FlowCr
-31-2
Free Cash Flow
Free Cash FlowCr
-823
CFO To PAT
CFO To PAT%
-43.1633.8-9.4
CFO To EBITDA
CFO To EBITDA%
22.5118.9-28.0

Ratios

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1471174452
Price To Earnings
Price To Earnings
17.5-1.0
Price To Sales
Price To Sales
0.40.40.20.2
Price To Book
Price To Book
1.10.80.40.5
EV To EBITDA
EV To EBITDA
14.05.7-9.7-17.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.332.9
OPM
OPM%
4.711.3-6.4-3.9
NPM
NPM%
-2.52.1-19.1-16.5
ROCE
ROCE%
1.28.3-15.8-15.8
ROE
ROE%
-6.74.5-43.1-43.1
ROA
ROA%
-2.71.8-14.1-14.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1471174452
Price To Earnings
Price To Earnings
17.5-1.0
Price To Sales
Price To Sales
0.40.40.20.2
Price To Book
Price To Book
1.10.80.40.5
EV To EBITDA
EV To EBITDA
14.05.7-9.7-17.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.332.9
OPM
OPM%
4.711.3-6.4-3.9
NPM
NPM%
-2.52.1-19.1-16.5
ROCE
ROCE%
1.28.3-15.8-15.8
ROE
ROE%
-6.74.5-43.1-43.1
ROA
ROA%
-2.71.8-14.1-14.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Mangalam Drugs and Organics Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/3lor6f7tdyfvpclulyjt7zym.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/1anv4fvpp7u0q3abamz1md4q.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/q41w7gff6kolg85iuf2p1k96.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/3wg3n0wz1646qs6t5vrr7lvk.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/xme5ikxlek23tjd2vgxlxi9j.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/v16czsehy34ciqsqfr6614bf.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/pph1vjml1zqr1by3fqh3rq02.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/fkxvymv7kws9dvkamu71lor0.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/zr2r3lh2a6xok2g6ivpzioau.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/b93jcbtjfmosxvsoecajrxpj.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/xri4kl0rjcuca3jrmgq7xvuj.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/74qfy6fdbtn93eujqmdjjmw4.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/ngty4z5onrf8jviur41nk36x.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/972yfaeecys1m7lviorwhzhr.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/sjnbg60sgerobdw4aqmf7423.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies